Introducing the New Pfizer/BioNTech LP.8.1 COVID-19 Vaccine at Woodstock Road Chemist
We are pleased to announce that Woodstock Road Chemist is rolling out the latest Pfizer/BioNTech LP.8.1-adapted COVID-19 vaccine (Comirnaty® LP.8.1), designed for the 2025-2026 season. This updated vaccine better matches the currently circulating strains of SARS-CoV-2, offering improved protection to our community.
What Is the LP.8.1 Vaccine?
-
Adapted formulation: LP.8.1 is a monovalent mRNA vaccine from Pfizer/BioNTech specifically tailored to target the LP.8.1 sublineage of SARS-CoV-2—one of the dominant strains in circulation.
-
Regulatory approval: The vaccine has received approval in the U.S. from the FDA for adults aged 65 and above and for individuals aged 5–64 who have one or more underlying health conditions that put them at increased risk of severe COVID-19.
-
Safety profile: Clinical trials and preclinical data show a safety profile consistent with earlier Pfizer COVID-19 vaccines, with no new safety concerns found in early studies.


